| Authors: |
Morand EF; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia. Electronic address: eric.morand@monash.edu., Werth VP; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, and Corporal Michael J Crecenz VAMC, Philadelphia, PA, USA., Wenzel J; Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany., Furie R; Division of Rheumatology, Northwell, Great Neck, NY, USA., Dall'Era M; Division of Rheumatology, University of California San Francisco School of Medicine, San Francisco, CA, USA., Sanchez-Guerrero J; Division of Rheumatology, Mount Sinai Hospital/Toronto Western Hospital, University of Toronto, Toronto, ON, Canada., Roy S; Ares Trading SA, an affiliate of Merck KGaA, Eysins, Switzerland., Goodson SG; EMD Serono Research amp; Development Institute, Inc, an affiliate of Merck KGaA, Billerica, MA, USA., Moreau F; EMD Serono Research amp; Development Institute, Inc, an affiliate of Merck KGaA, Billerica, MA, USA., Gühring H; Merck Healthcare KGaA, Darmstadt, Germany., Sgouroudi E; Merck Healthcare KGaA, Darmstadt, Germany., Klopp-Schulze L; Merck Healthcare KGaA, Darmstadt, Germany., Pearson DR; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA. |
